Novartis Pharmaceuticals Corporation and Novartis Pharma AG v. Teva Pharmaceuticals USA Inc
D.N.J. 2009
Fitzpatrick Successfully Defends Novartis Pharmaceuticals in Famvir Patent Infringement Case.
Fitzpatrick successfully obtained a jury verdict of no invalidity and no inequitable conduct on behalf of its client Novartis Pharmaceutical against Teva Pharmaceuticals in a litigation involving the patent on the herpes drug famciclovir. The jury deliberated 4 hours before announcing its verdict, November 18, 2009 in Federal District Court of New Jersey, Newark section, before District Judge Dennis M. Cavanaugh.
The Fitzpatrick team was led by partners Robert Baechtold, Lisa Pensabene, Nicholas Kallas and Simon Roberts, and co-counsel for Novartis was Cravath, Swaine & Moore.
Back to Representative Cases
D.N.J. 2009
Fitzpatrick Successfully Defends Novartis Pharmaceuticals in Famvir Patent Infringement Case.
Fitzpatrick successfully obtained a jury verdict of no invalidity and no inequitable conduct on behalf of its client Novartis Pharmaceutical against Teva Pharmaceuticals in a litigation involving the patent on the herpes drug famciclovir. The jury deliberated 4 hours before announcing its verdict, November 18, 2009 in Federal District Court of New Jersey, Newark section, before District Judge Dennis M. Cavanaugh.
The Fitzpatrick team was led by partners Robert Baechtold, Lisa Pensabene, Nicholas Kallas and Simon Roberts, and co-counsel for Novartis was Cravath, Swaine & Moore.
Back to Representative Cases
